Characterization of the novel HLA-C*02:185 allele in a kidney transplant recipient.

Alleles HLA-C Antigens / genetics Histocompatibility Testing Humans Kidney Transplantation Sequence Analysis, DNA
HLA-C*02:185 NGS human leucocyte antigen novel HLA allele

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
09 2020
Historique:
received: 16 04 2020
accepted: 17 04 2020
pubmed: 21 4 2020
medline: 22 6 2021
entrez: 21 4 2020
Statut: ppublish

Résumé

HLA-C*02:185 differs from HLA-C*02:02:02:01 by one nucleotide substitution at codon 180 in exon 3.

Identifiants

DOI: 10.1111/tan.13911 PMID: 32309910
pubmed: 32309910
doi: 10.1111/tan.13911
doi:

Substances chimiques

HLA-C Antigens 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

352-353

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Barker DJ, Georgiou X, Ma C, Flicek P, SGE M. IPD-IGT/HLA Database. Nucleic Acids Res. 2020;48:D948-D955.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system. Tissue Antigens. 2010;75:291-455.

Auteurs

Céline Dard (C)

Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du sang Auvergne-Rhône-Alpes, Grenoble, France.
ORCID: 0000-0002-5843-0842

Ornella Senoussi (O)

Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du sang Auvergne-Rhône-Alpes, Grenoble, France.

Vincent Elsermans (V)

Institut d'Immunologie - HLA, CHRU de Lille, Lille, France.
ORCID: 0000-0002-0881-0695

Béatrice Bardy (B)

Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du sang Auvergne-Rhône-Alpes, Grenoble, France.

Dominique Masson (D)

Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du sang Auvergne-Rhône-Alpes, Grenoble, France.
ORCID: 0000-0002-6995-4713

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › Characterization of the novel HLA-C*02:185...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-C › Characterization of the novel HLA-C*02:185...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Tests immunologiques › Test d'histocompatibilité › Characterization of the novel HLA-C*02:185...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Characterization of the novel HLA-C*02:185...
questionsmedicales.fr › Procédures de chirurgie opératoire › Procédures de chirurgie urogénitale › Procédures de chirurgie urologique › Transplantation rénale › Characterization of the novel HLA-C*02:185...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Characterization of the novel HLA-C*02:185...